Starbird, the 1997 Naismith Player of the Year, was excited to play in her hometown for Seattle's ABL franchise. To seal the deal, the ABL offered her a contract that according to reports at the ...

National firm ABL 1 Touch has been announced as the tenant of the first unit constructed within the £200million Business Park South development, marking a milestone in the park’s growth.

ELVN-001 targets the BCR-ABL gene fusion, addressing resistance ... mutation and confers resistance to all generations of tyrosine kinase inhibitors. A number of molecules, some of which have ...

The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow.

Background: The treatment of chronic myeloid leukemia through tyrosine kinase inhibitors (TKIs) has achieved promising efficacy and safety outcomes, however the costs are associated with a substantial ...